data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Solid Biosciences
(NASDAQ:SLDB)
$0.576
-0.0396[-6.43%]
At close: Jul 1
$0.575
-0.0010[-0.17%]
After Hours: 5:22PM EDT
Day High/Low0.55 - 0.63
52 Week High/Low0.42 - 3.77
Open / Close0.62 / 0.58
Float / Outstanding84.7M / 112.8M
Vol / Avg.1.3M / 769K
Mkt Cap65M
P/E-
50d Avg. Price0.58
Div / Yield-
Payout Ratio-
EPS-0.22
Total Float84.7M

Solid Biosciences (NASDAQ:SLDB), Quotes and News Summary

Solid Biosciences (NASDAQ: SLDB)

Day High/Low0.55 - 0.63
52 Week High/Low0.42 - 3.77
Open / Close0.62 / 0.58
Float / Outstanding84.7M / 112.8M
Vol / Avg.1.3M / 769K
Mkt Cap65M
P/E-
50d Avg. Price0.58
Div / Yield-
Payout Ratio-
EPS-0.22
Total Float84.7M
Benzinga - May 19, 2022, 7:25AM
Benzinga - Apr 28, 2022, 7:10AM
Benzinga - Apr 28, 2022, 5:08AM
Benzinga - Apr 28, 2022, 5:07AM
Benzinga - Apr 27, 2022, 1:35PM
Benzinga - Apr 27, 2022, 7:40AM
Benzinga - Mar 14, 2022, 12:41PM
Benzinga - Mar 14, 2022, 8:12AM
load more
Sector: Health Care.Industry: Biotechnology
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of speciality and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-09-14
REV
Q1 2022Est.ActualSurprise
EPS-0.180-0.220 -0.0400
REV2.680M1.925M-755.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Solid Biosciences Questions & Answers

Q
How do I buy Solid Biosciences (SLDB) stock?
A

You can purchase shares of Solid Biosciences (NASDAQ: SLDB) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Solid Biosciences's (SLDB) competitors?
Q
What is the target price for Solid Biosciences (SLDB) stock?
A

The latest price target for Solid Biosciences (NASDAQ: SLDB) was reported by Piper Sandler on Thursday, May 19, 2022. The analyst firm set a price target for 2.00 expecting SLDB to rise to within 12 months (a possible 247.22% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Solid Biosciences (SLDB)?
A

The stock price for Solid Biosciences (NASDAQ: SLDB) is $0.576 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Solid Biosciences (SLDB) pay a dividend?
A

There are no upcoming dividends for Solid Biosciences.

Q
When is Solid Biosciences (NASDAQ:SLDB) reporting earnings?
A

Solid Biosciences’s Q2 earnings are confirmed for Wednesday, September 14, 2022.

Q
Is Solid Biosciences (SLDB) going to split?
A

There is no upcoming split for Solid Biosciences.

Q
What sector and industry does Solid Biosciences (SLDB) operate in?
A

Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.